Innovation, Research
Ribonexus: Overcoming resistance to cancer treatments
… complex provided by Pierre Fabre’s laboratory, after a licence agreement was signed in November 2021 for … complex provided by Pierre Fabre’s laboratory, after a licence agreement was signed in November 2021 for …Published on: Thu 28/04/2022 - 13:57